The Ir(III) fragment {Ir(PCy(3))(2)(H)(2)}(+) has been used to probe the role of the metal centre in the catalytic dehydrocoupling of H(3)B⋅NMe(2)H (A) to ultimately give dimeric aminoborane [H(2)BNMe(2)](2) (D). Addition of A to [Ir(PCy(3))(2)(H)(2)(H(2))(2)][BAr(F)(4)] (1; Ar(F) = (C(6)H(3)(CF(3))(2)), gives the amine-borane complex [Ir(PCy(3))(2)(H)(2)(H(3)B⋅NMe(2)H)][BAr(F)(4)] (2 a), which slowly dehydrogenates to afford the aminoborane complex [Ir(PCy(3))(2)(H)(2)(H(2)B-NMe(2))][BAr(F)(4)] (3). DFT calculations have been used to probe the mechanism of dehydrogenation and show a pathway featuring sequential BH activation/H(2) loss/NH activation. Addition of D to 1 results in retrodimerisation of D to afford 3. DFT calculations indicate that this involves metal trapping of the monomer-dimer equilibrium, 2 H(2)BNMe(2) ⇌ [H(2)BNMe(2)](2). Ruthenium and rhodium analogues also promote this reaction. Addition of MeCN to 3 affords [Ir(PCy(3))(2)(H)(2)(NCMe)(2)][BAr(F)(4)] (6) liberating H(2)B-NMe(2) (B), which then dimerises to give D. This is shown to be a second-order process. It also allows on- and off-metal coupling processes to be probed. Addition of MeCN to 3 followed by A gives D with no amine-borane intermediates observed. Addition of A to 3 results in the formation of significant amounts of oligomeric H(3)B⋅NMe(2)BH(2)⋅NMe(2)H (C), which ultimately was converted to D. These results indicate that the metal is involved in both the dehydrogenation of A, to give B, and the oligomerisation reaction to afford C. A mechanism is suggested for this latter process. The reactivity of oligomer C with the Ir complexes is also reported. Addition of excess C to 1 promotes its transformation into D, with 3 observed as the final organometallic product, suggesting a B-N bond cleavage mechanism. Complex 6 does not react with C, but in combination with B oligomer C is consumed to eventually give D, suggesting an additional role for free aminoborane in the formation of D from C.
The coordination chemistry of diisopropylaminoborane H 2 B-N i Pr 2 with valence isoelectronic metal fragments to form, essentially isostructural, [MH 2 (η 2 :η 2 -H 2 B-N i Pr 2 )(PCy 3 ) 2 ] nþ (M = Ru, n = 0; Rh and Ir, n = 1) has been explored by a combination of X-ray crystallography, NMR spectroscopy, and computational techniques. In the solid state and solution the aminoborane interacts with the metal centers through one four-center four-electron interaction, forming bis(σ-B-H) complexes. The structural data point to tighter interactions between both the Ru and Ir congeners compared to the Rh with significantly shorter M 3 3 3 B distances in the first two. These tighter interactions are mirrored in the spectroscopic data, with the Ru and Ir complexes showing more deshielded 11 B chemical shifts and 1 H M-H-B resonances that are more shielded than observed for the rhodium complex. Analysis of the bonding between metal and borane using the NBO approach is in very good agreement with the variations in the geometrical and spectroscopic parameters. There is overall a stronger interaction between the borane and the metal fragment for neutral Ru compared to cationic Rh, with cationic Ir in an intermediate situation. † Part of the Dietmar Seyferth Festschrift. In honor of Prof. Dr. h.c. mult. Dietmar Seyferth for his outstanding contribution as Editor of Organometallics.
A new robust and high-yielding synthesis of the valuable U(III) synthon [U(BH4)3(THF)2] is reported. Reactivity in ligand exchange reactions is found to contrast significantly to that of uranium triiodide. This is exemplified by the synthesis and characterization of azamacrocyclic U(III) complexes, including mononuclear [U(BH4)(L)] and dinuclear [Li(THF)4][{U(BH4)}2(μ-BH4)(L(Me))] and [Na(THF)4][{U(BH4)}2(μ-BH4)(L(A))(THF)2]. The structures of all complexes have been determined by single-crystal X-ray diffraction and display two new U(III)2(BH4)3 motifs.
The first use of a dinuclear UIII/UIII complex in the activation of small molecules is reported.
The computationally- and experimentally-determined molecular structures of a bis-uranyl(vi) complex of an expanded Schiff-base polypyrrolic macrocycle [(UO)(L)] are in close agreement only if the pyridine in the fifth equatorial donor site on the uranium is included in the calculations. The relativistic density functional theory (DFT) calculations presented here are augmented from those on previously reported simpler frameworks, and demonstrate that other augmentations, such as the incorporation of condensed-phase media and the changes in the peripheral groups of the ligand, have only a slight effect. Synthetic routes to pure samples of the bis- and mono-uranyl(vi) complexes have been developed using pyridine and arene solvents, respectively, allowing the experimental determination of the molecular structures by X-ray single crystal diffraction; these agree well with the calculated structures. A comprehensive set of calculations has been performed on a series of actinyl AnO complexes of this macrocyclic ligand. These include both bis- and mono-actinyl adducts for the metals U, Np and Pu, and formal oxidation states VI and V. The reduction potentials of the complexes for U, Np, and Pu, incorporating both solvation and spin-orbit coupling considerations, show the order Np > Pu > U. The agreement between experimental and computed data for U is excellent, suggesting that at this level of computation predictions made about the significantly more radiotoxic Np and Pu molecules should be accurate. A particularly unusual structure of the mononuclear plutonyl(v) complex was predicted by quantum chemical calculations, in which a twist in the macrocycle allows one of the two endo-oxo groups to form a hydrogen bond to one pyrrole group of the opposite side of the macrocycle, in accordance with this member of the set containing the most Lewis basic oxo groups.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.